Gene · 7409
Papers3,486
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,486
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD11c+ myeloid cell exosomes reduce intestinal inflammation during colitis. | JCI Insight | 2022 | 36214220 | PubTator, text mining | PubMed |
| Role of TET dioxygenases in the regulation of both normal and pathological hematopoiesis. | J Exp Clin Cancer Res | 2022 | 36203205 | PubTator, text mining | PubMed |
| Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness. | Front Endocrinol (Lausanne) | 2022 | 36187116 | PubTator, text mining | PubMed |
| A Soluble NK-CAR Mediates the Specific Cytotoxicity of NK Cells toward the Target CD20+ Lymphoma Cells. | Aging Dis | 2022 | 36186137 | PubTator, text mining | PubMed |
| BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies. | J Hematol Oncol | 2022 | 36183125 | PubTator, text mining | PubMed |
| Microarray meta-analysis reveals IL6 and p38β/MAPK11 as potential targets of hsa-miR-124 in endothelial progenitor cells: Implications for stent re-endothelization in diabetic patients. | Front Cardiovasc Med | 2022 | 36176980 | PubTator, text mining | PubMed |
| Nexinhib20 Inhibits Neutrophil Adhesion and β2 Integrin Activation by Antagonizing Rac-1-Guanosine 5'-Triphosphate Interaction. | J Immunol | 2022 | 36165184 | PubTator, text mining | PubMed |
| [Enhanced Natural Killers with CISH and B2M Gene Knockouts Reveal Increased Cytotoxicity in Glioblastoma Primary Cultures]. | Mol Biol (Mosk) | 2022 | 36165021 | PubTator, text mining | PubMed |
| Intrahepatic activated leukocyte cell adhesion molecule induces CD6highCD4+ T cell infiltration in autoimmune hepatitis. | Front Immunol | 2022 | 36159854 | PubTator, text mining | PubMed |
| Fyn expression is associated with the response of patients with locally advanced uterine cervical squamous cell carcinoma to neoadjuvant chemotherapy. | Mol Clin Oncol | 2022 | 36157319 | PubTator, text mining | PubMed |
| Small GTPase-A Key Role in Host Cell for Coronavirus Infection and a Potential Target for Coronavirus Vaccine Adjuvant Discovery. | Viruses | 2022 | 36146850 | PubTator, text mining | PubMed |
| Identification of AGR2 Gene-Specific Expression Patterns Associated with Epithelial-Mesenchymal Transition. | Int J Mol Sci | 2022 | 36142758 | PubTator, text mining | PubMed |
| Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches. | Diagnostics (Basel) | 2022 | 36140539 | PubTator, text mining | PubMed |
| Resveratrol Downmodulates Neutrophil Extracellular Trap (NET) Generation by Neutrophils in Patients with Severe COVID-19. | Antioxidants (Basel) | 2022 | 36139764 | PubTator, text mining | PubMed |
| Co-Stimulatory Receptor Signaling in CAR-T Cells. | Biomolecules | 2022 | 36139142 | PubTator, text mining | PubMed |
| Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies. | Biomolecules | 2022 | 36139103 | PubTator, text mining | PubMed |
| A report on the potential of Rac1/pSTAT3 protein levels in T lymphocytes to assess the pharmacodynamic effect of thiopurine therapy in Inflammatory Bowel Disease patients. | Sci Rep | 2022 | 36138194 | PubTator, text mining | PubMed |
| HLA-DRB1: A new potential prognostic factor and therapeutic target of cutaneous melanoma and an indicator of tumor microenvironment remodeling. | PLoS One | 2022 | 36129956 | PubTator, text mining | PubMed |
| Unraveling the actin cytoskeleton in the malignant transformation of cholangiocyte biology. | Transl Oncol | 2022 | 36113344 | PubTator, text mining | PubMed |
| The hedgehog pathway in hematopoiesis and hematological malignancy. | Front Oncol | 2022 | 36091167 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7409/papers?page=20